Creating a new imaging tool to study Alzheimer's disease
Official title: Development of Highly Multiplexed Raman Imaging Platform for Alzheimer’s Disease
Funded at University of Southern California · NIH-11055758 · Data updated 2026-11-12
This study is working on a new imaging tool to look closely at brain tissue from people with Alzheimer's, helping us see how the immune system and brain cells change with the disease, which could lead to better treatments in the future.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project start | January 1, 2025 |
| Project end | December 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $124,562 |
| NIH project number | 1K99EB035706-01A1 |
| Project ID | NIH-11055758 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those showing early signs of cognitive decline.
✕Less likely to help
Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
What this research studies
This research focuses on developing a cutting-edge imaging platform that can analyze multiple biomarkers in brain tissue samples from Alzheimer's disease patients. By using advanced nanoparticle technology, the study aims to visualize and understand the complex immune responses and cellular changes associated with Alzheimer's. This innovative approach will allow researchers to capture detailed information about the brain's pathology in a single imaging session, which could lead to better therapeutic strategies. The project is designed to enhance our understanding of how the immune system interacts with Alzheimer's disease.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment strategies for Alzheimer's disease.
How similar studies have gone: Previous research has shown promise in using advanced imaging techniques to study neurodegenerative diseases, indicating that this approach could yield valuable insights.
Where this research is happening
-
University of Southern California
Los Angeles, United States Active
Researchers
- Principal investigator: Eremina, Olga E. — University of Southern California
- Study coordinator: Eremina, Olga E.
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.